The core activity of Novostia is the development and manufacture of medical devices, particularly heart valves, as well as the conduct of clinical trials and the obtaining of approvals (CE marking, FDA clearance) for these products.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
✓ Offered3
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Artificial heart valve for aortic and mitral applications, with tri-leaflet design, low thrombogenicity, lifespan and low noise generation; investigated in vitro and in vivo, not yet approved for sale.
Preclinical testing and evidence for heart valves
In-vitro and in-vivo tests to validate hydrodynamics, structural performance, durability and wear; comparative testing by independent institutes and long-term implantations without anticoagulant.
Heart valve technology for aortic and mitral indications
Heart valve technology for patients with aortic and mitral valve diseases, including young patients, children and operable patients who need valve replacement.
Knowledge
No knowledge articles yet
Once Novostia SA has claimed this profile, we'll publish editorial articles and case studies here together.